Loading...
Rocket Lab Corp (RKLB) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has strong growth potential in the space industry and a growing backlog, the current pre-market price drop of -5.56% and mixed financial performance, including a net loss and declining EPS, suggest caution. Additionally, there are no strong proprietary trading signals or recent congress trading data to support immediate action. Holding off for more clarity on the company's execution and financial improvements is advisable.
The technical indicators show a neutral trend. The MACD is below 0 and negatively contracting, RSI is neutral at 53.156, and moving averages are converging. The stock is trading near its pivot level of 70.964, with key support at 65.49 and resistance at 76.438. The pre-market price drop of -5.56% indicates potential short-term weakness.

Record annual revenue of $602 million for
Growing backlog of $1.85 billion.
Recent contract wins, including a multi-launch agreement with BlackSky Technology.
Analysts have raised price targets, with some expecting significant growth in the space industry.
Pre-market price drop of -5.56%.
Insider selling has increased significantly by 2217.13% over the last month.
Potential delays in Neutron's initial launch due to a tank rupture.
Net loss of $0.09 per share in Q4 2025 and declining EPS.
Rocket Lab reported Q4 2025 revenue of $179.65 million, achieving a 100% success rate with seven launches. However, the company posted a net loss of $0.09 per share. For 2025/Q3, revenue increased by 47.97% YoY, but net income dropped by -64.85% YoY, and EPS declined by -70.00% YoY.
Analysts are generally positive on Rocket Lab, with multiple firms maintaining Buy ratings and raising price targets (e.g., TD Cowen: $100, BofA: $120, Morgan Stanley: $105). However, some concerns about potential launch delays and mixed ratings (e.g., Goldman Sachs: Neutral) temper the overall sentiment.